Michael Giordano

Director/Board Member at RAPT THERAPEUTICS, INC.

Net worth: 36 117 $ as of 29/04/2024

66 year

99 connections

Health Technology

Consumer Services

Government

Active connections

Name	Gender	Age	Linked companies	Collaboration
Christopher Boerner	M	53	BRISTOL-MYERS SQUIBB COMPANY	9 years
Karl Peggs	M	57	ACHILLES THERAPEUTICS PLC Achilles Therapeutics UK Ltd. Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Achilles Therapeutics Ltd. operates as a biopharmaceutical company. The firm develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer. It uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. The company was founded by Karl Peggs, Mark Lowdell, Charles Swanton and Sergio Quezada in May 2016 and is headquartered in London, the United Kingdom.	8 years
Phil Holzer	M	48	BRISTOL-MYERS SQUIBB COMPANY	11 years
Edwin Moses	M	69	ACHILLES THERAPEUTICS PLC Achilles Therapeutics UK Ltd. Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Achilles Therapeutics Ltd. operates as a biopharmaceutical company. The firm develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer. It uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. The company was founded by Karl Peggs, Mark Lowdell, Charles Swanton and Sergio Quezada in May 2016 and is headquartered in London, the United Kingdom.	6 years
Iraj Ali	M	48	ACHILLES THERAPEUTICS PLC Achilles Therapeutics UK Ltd. Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Achilles Therapeutics Ltd. operates as a biopharmaceutical company. The firm develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer. It uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. The company was founded by Karl Peggs, Mark Lowdell, Charles Swanton and Sergio Quezada in May 2016 and is headquartered in London, the United Kingdom.	6 years
Derek DiRocco	M	43	ACHILLES THERAPEUTICS PLC Achilles Therapeutics UK Ltd. Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Achilles Therapeutics Ltd. operates as a biopharmaceutical company. The firm develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer. It uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. The company was founded by Karl Peggs, Mark Lowdell, Charles Swanton and Sergio Quezada in May 2016 and is headquartered in London, the United Kingdom.	4 years
Carsten Boess	M	57	ACHILLES THERAPEUTICS PLC Achilles Therapeutics UK Ltd. Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Achilles Therapeutics Ltd. operates as a biopharmaceutical company. The firm develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer. It uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. The company was founded by Karl Peggs, Mark Lowdell, Charles Swanton and Sergio Quezada in May 2016 and is headquartered in London, the United Kingdom.	4 years
Brian Wong	M	52	RAPT THERAPEUTICS, INC.	9 years
Linda Kozick	F	66	RAPT THERAPEUTICS, INC. BRISTOL-MYERS SQUIBB COMPANY	13 years
William Rieflin	M	64	RAPT THERAPEUTICS, INC.	9 years
Mary Gray	M	71	RAPT THERAPEUTICS, INC.	5 years
Kimberly McCutcheon Jablonski	F	-	BRISTOL-MYERS SQUIBB COMPANY	21 years
Wendye Robbins	M	63	RAPT THERAPEUTICS, INC.	5 years
Peter Arduini	M	59	BRISTOL-MYERS SQUIBB COMPANY	8 years
Lori Lyons-Williams	F	46	RAPT THERAPEUTICS, INC.	3 years
Rodney Young	M	61	RAPT THERAPEUTICS, INC.	5 years
Sergio Quezada	M	49	ACHILLES THERAPEUTICS PLC	4 years
Louis Schmukler	M	-	BRISTOL-MYERS SQUIBB COMPANY	13 years
Daniel Hood	M	-	ACHILLES THERAPEUTICS PLC	-
Bernhard R. M. Ehmer	M	69	ACHILLES THERAPEUTICS PLC	2 years
William Perhacs	M	-	BRISTOL-MYERS SQUIBB COMPANY	17 years
Robert Coutts	M	40	ACHILLES THERAPEUTICS PLC	4 years
Zack Newman	M	-	BRISTOL-MYERS SQUIBB COMPANY	11 years
Pete Feldman	M	-	Oncovalent Therapeutics, Inc. Oncovalent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Oncovalent Therapeutics, Inc. develops immuno oncology drugs and therapeutics. The company is based in Thousand Oaks, CA. Pete Feldman has been the CEO of the company since 2020.	4 years
Jim Farmer	M	-	RAPT THERAPEUTICS, INC.	2 years
James Taylor	M	-	ACHILLES THERAPEUTICS PLC	2 years
Adnan Rahman	M	-	RAPT THERAPEUTICS, INC.	2 years
Michael Listgarten	M	-	RAPT THERAPEUTICS, INC.	1 years
Edward Samuel	M	-	ACHILLES THERAPEUTICS PLC	2 years
Tariq Ahmed	M	-	ACHILLES THERAPEUTICS PLC	4 years
Shree Patel	M	-	ACHILLES THERAPEUTICS PLC	-
Liz Elmhirst	F	-	Achilles Therapeutics UK Ltd. Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Achilles Therapeutics Ltd. operates as a biopharmaceutical company. The firm develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer. It uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. The company was founded by Karl Peggs, Mark Lowdell, Charles Swanton and Sergio Quezada in May 2016 and is headquartered in London, the United Kingdom.	-
Nipun Davar	M	-	RAPT THERAPEUTICS, INC.	-
Shari L. Geffon	F	-	RAPT THERAPEUTICS, INC.	2 years
Jennifer Nicholson	F	-	RAPT THERAPEUTICS, INC.	2 years
Tim Power	M	-	BRISTOL-MYERS SQUIBB COMPANY	18 years
Lisa Moore	M	-	RAPT THERAPEUTICS, INC.	6 years
Paul Kassner	M	58	RAPT THERAPEUTICS, INC.	8 years
Aljanae Reynolds	M	-	RAPT THERAPEUTICS, INC.	-
Elisa Petris	M	45	Achilles Therapeutics UK Ltd. Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Achilles Therapeutics Ltd. operates as a biopharmaceutical company. The firm develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer. It uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. The company was founded by Karl Peggs, Mark Lowdell, Charles Swanton and Sergio Quezada in May 2016 and is headquartered in London, the United Kingdom.	8 years
Martin Murphy	M	55	Achilles Therapeutics UK Ltd. Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Achilles Therapeutics Ltd. operates as a biopharmaceutical company. The firm develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer. It uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. The company was founded by Karl Peggs, Mark Lowdell, Charles Swanton and Sergio Quezada in May 2016 and is headquartered in London, the United Kingdom.	-
Rogier Rooswinkel	M	-	Achilles Therapeutics UK Ltd. Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Achilles Therapeutics Ltd. operates as a biopharmaceutical company. The firm develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer. It uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. The company was founded by Karl Peggs, Mark Lowdell, Charles Swanton and Sergio Quezada in May 2016 and is headquartered in London, the United Kingdom.	-
Julie O'Neill	F	58	ACHILLES THERAPEUTICS PLC	3 years
Gwen R. Carscadden	F	62	RAPT THERAPEUTICS, INC.	2 years
William Ho	M	58	RAPT THERAPEUTICS, INC.	9 years
David J. Wustrow	M	65	RAPT THERAPEUTICS, INC.	8 years
Sylvia R. Wheeler	F	63	RAPT THERAPEUTICS, INC.	-
Dirk Brockstedt	M	55	RAPT THERAPEUTICS, INC.	6 years
Dara Henry	M	-	Achilles Therapeutics UK Ltd. Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Achilles Therapeutics Ltd. operates as a biopharmaceutical company. The firm develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer. It uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. The company was founded by Karl Peggs, Mark Lowdell, Charles Swanton and Sergio Quezada in May 2016 and is headquartered in London, the United Kingdom.	-

Connections Chart

Multi-company connection

Former connections

Name	Gender	Age	Linked companies	Collaboration
Giovanni Caforio	M	59	BRISTOL-MYERS SQUIBB COMPANY	24 years
James Cornelius	M	81	BRISTOL-MYERS SQUIBB COMPANY	10 years
Peter R. Dolan	M	68	BRISTOL-MYERS SQUIBB COMPANY	18 years
Charles A. Heimbold	M	-	BRISTOL-MYERS SQUIBB COMPANY	20 years
John E. Celentano	M	64	BRISTOL-MYERS SQUIBB COMPANY	31 years
Thomas Lynch	M	63	BRISTOL-MYERS SQUIBB COMPANY	5 years
Togo Dennis West	M	81	BRISTOL-MYERS SQUIBB COMPANY	10 years
Peter Svennilson	M	62	RAPT THERAPEUTICS, INC.	1 years
Joseph Squicciarino	M	67	BRISTOL-MYERS SQUIBB COMPANY	22 years
Gerald Bruce	M	68	BRISTOL-MYERS SQUIBB COMPANY	8 years
Brian Daniels	M	65	BRISTOL-MYERS SQUIBB COMPANY	14 years
David J. Helfgott	M	-	BRISTOL-MYERS SQUIBB COMPANY	-
Mark W. Durand	M	64	BRISTOL-MYERS SQUIBB COMPANY	17 years
Vicki Sato	M	75	BRISTOL-MYERS SQUIBB COMPANY	15 years
John E. Elicker	M	64	BRISTOL-MYERS SQUIBB COMPANY	20 years
Douglas Manion	M	64	BRISTOL-MYERS SQUIBB COMPANY	11 years
Rosemary Crane	F	64	BRISTOL-MYERS SQUIBB COMPANY	20 years
Carl Decicco	M	62	BRISTOL-MYERS SQUIBB COMPANY	10 years
Eric J. Hall	M	69	RAPT THERAPEUTICS, INC.	-
Jason Haddock	M	54	BRISTOL-MYERS SQUIBB COMPANY	14 years
John Tsai	M	57	BRISTOL-MYERS SQUIBB COMPANY	11 years
Harrison Bains	M	80	BRISTOL-MYERS SQUIBB COMPANY	16 years
Gerald Storch	M	67	BRISTOL-MYERS SQUIBB COMPANY	12 years
David Goeddel	M	72	RAPT THERAPEUTICS, INC.	5 years
Béatrice J. Cazala	F	67	BRISTOL-MYERS SQUIBB COMPANY	32 years
Charles Sigal	M	72	BRISTOL-MYERS SQUIBB COMPANY	16 years
Anthony Hooper	M	69	BRISTOL-MYERS SQUIBB COMPANY	15 years
Louis J. Freeh	M	74	BRISTOL-MYERS SQUIBB COMPANY	8 years
Timothy Meeker	M	77	BRISTOL-MYERS SQUIBB COMPANY	13 years
Dinesh C. Paliwal	M	67	BRISTOL-MYERS SQUIBB COMPANY	8 years
Robert Williams	M	75	BRISTOL-MYERS SQUIBB COMPANY	7 years
Barry J. Wolfenson	M	57	BRISTOL-MYERS SQUIBB COMPANY	23 years
James Robinson	M	88	BRISTOL-MYERS SQUIBB COMPANY	29 years
Louis Gerstner	M	-	BRISTOL-MYERS SQUIBB COMPANY	-
Michael Grobstein	M	81	BRISTOL-MYERS SQUIBB COMPANY	13 years
Alan J. Lacy	M	70	BRISTOL-MYERS SQUIBB COMPANY	12 years
Leif Valdemar Johansson	M	73	BRISTOL-MYERS SQUIBB COMPANY	13 years
Lewis B. Campbell	M	77	BRISTOL-MYERS SQUIBB COMPANY	18 years
Robert E. Allen	M	-	BRISTOL-MYERS SQUIBB COMPANY	21 years
Mark Neumann	M	-	BRISTOL-MYERS SQUIBB COMPANY	26 years
Donald Hayden	M	68	BRISTOL-MYERS SQUIBB COMPANY	25 years
Kirsten Detrick	F	59	BRISTOL-MYERS SQUIBB COMPANY	13 years
Mohamed Ragab	M	-	BRISTOL-MYERS SQUIBB COMPANY	-
David Ian Johnson	M	66	BRISTOL-MYERS SQUIBB COMPANY	12 years
Stephen McAndrew	M	-	BRISTOL-MYERS SQUIBB COMPANY	8 years
Fabio M. Benedetti	M	58	BRISTOL-MYERS SQUIBB COMPANY	3 years
Erik Harris	M	54	BRISTOL-MYERS SQUIBB COMPANY	2 years
Richard L. Wolgemuth	M	78	BRISTOL-MYERS SQUIBB COMPANY	-
Myrtle Potter	F	65	BRISTOL-MYERS SQUIBB COMPANY	4 years
Lynn Sadowski Mason	F	45	BRISTOL-MYERS SQUIBB COMPANY	2 years

Statistics

Country	Connections	% of total
United States	80	80.81%
United Kingdom	19	19.19%

Age of Connections

Active

Past

Male

Female

Members of the board

Executives

Origin of connections